| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 2e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 4e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |